Your bodys needs are dynamic, shifting with stress, diet changes, or new health challenges
The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis
Steady, confident administration : A steady, well-paced injection pace reduces the burning sensation that can occur with shaky or too-rapid delivery
This powerful combination leverages both biological science and advanced technology to deliver visible, lasting results
CJC-1295 enhances the natural rhythm of growth hormone pulses, while ipamorelin may trigger the release of growth hormones